Welcome to our dedicated page for Esquire Finl Hldgs SEC filings (Ticker: ESQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Esquire Financial Holdings, Inc. filings document the public-company record for a Maryland financial holding company whose common stock trades on Nasdaq under ESQ and whose bank subsidiary is Esquire Bank, National Association.
The filing record includes Form 8-K disclosures for earnings releases, Regulation FD presentations, regular dividend actions, material agreements, and director or committee changes. Proxy materials cover annual-meeting governance, director matters, executive compensation, equity awards, pay-versus-performance data, and shareholder voting matters. The disclosures also identify the company's capital structure, banking subsidiary, Nasdaq-listed common stock, and governance framework.
Esquire Financial Holdings, Inc. Vice Chairman, President & CEO and director reported a disposition of 5,785 shares of common stock on 12/16/2025 at a price of $106.82 per share, coded as transaction type F. Following this transaction, the reporting person beneficially owns 270,452 shares of common stock.
These holdings include multiple grants of restricted stock that vest in three equal annual installments beginning on various dates from December 19, 2023 through January 30, 2028. The filer also holds stock options covering 29,250 shares of common stock with a $12.5 exercise price, which became exercisable on 09/01/2017 and expire on 09/01/2026 and are described as fully vested.
Esquire Financial Holdings, Inc. executive vice president and chief operating officer Eric S. Bader reported equity transactions in company stock. On 12/16/2025, 3,293 shares of common stock were disposed of in a transaction coded "F" at $106.82 per share, typically indicating shares withheld to cover taxes on vesting. After this, he beneficially owned 126,365 shares of common stock directly and 2,000 shares indirectly through an IRA. He also held fully vested stock options with an exercise price of $12.5 per share covering 14,125 shares of common stock, exercisable from 09/01/2017 until expiration on 09/01/2026. Several portions of his holdings include restricted stock scheduled to vest in three equal annual installments from 12/19/2023 through 01/30/2028.
Esquire Financial Holdings, Inc. reported an insider equity transaction by its EVP and Head of Corporate Development. The Form 4 shows a transaction in common stock2,229 shares$106.82100,418 shares1,947 shares
The filing also lists fully vested stock options$12.57,500 shares11,125 shares
Esquire Financial Holdings, Inc. reported an insider stock transaction by its SVP & Chief Financial Officer. On 12/16/2025, the officer disposed of 240 shares of common stock in a transaction coded “F” at a price of $106.82 per share, typically indicating shares withheld to cover taxes on equity vesting. Following this, the officer beneficially owns 16,622 shares of common stock directly and 3,250 shares indirectly through an IRA.
The filing also lists several stock option awards on common stock with exercise prices from $20.85 to $48.32 and expiration dates between 12/10/2028 and 12/15/2033. Some options are fully vested, while others vest in three equal annual installments beginning on dates in 2023 and 2024.
Esquire Financial Holdings, Inc. reported that one of its directors received a grant of 753 shares of restricted common stock on December 10, 2025, at a stated price of $0 per share. These restricted shares are scheduled to vest 100% on December 10, 2026.
After this grant, the reporting person beneficially owns 59,400 shares of common stock, including multiple prior restricted stock awards that vest in annual installments from December 19, 2023 through December 15, 2027. The director also holds 1,500 fully vested stock options with an exercise price of $24.9 per share, expiring on December 10, 2028.
Esquire Financial Holdings, Inc. disclosed that one of its directors acquired 753 shares of restricted common stock on December 10, 2025 at a price of $0 per share. These restricted shares vest 100% on December 10, 2026.
Following this award, the director beneficially owns 15,716 shares of common stock directly, along with indirect holdings of 25,500 shares as trustee for a trust, 12,600 shares through a limited partnership, 79,033 shares through another trust, and 21,001 shares through a profit sharing plan. The filing notes that these totals include multiple restricted stock grants scheduled to vest in three equal annual installments beginning on various dates between December 19, 2023 and December 15, 2027.
Esquire Financial Holdings, Inc. reported that one of its directors acquired 753 shares of common stock on December 10, 2025 at a price of $0, reflecting a grant of restricted stock.
These 753 restricted shares vest 100% on December 10, 2026. Following this award, the director beneficially owns 4,436 common shares directly and also holds 9,786 shares indirectly through an LLC II, 6,000 shares indirectly through the director's mother, and 127,531 shares indirectly through an LLC I, including restricted stock scheduled to vest in three equal annual installments beginning in 2026 and 2027.
Esquire Financial Holdings, Inc. reported an insider equity award by one of its directors. On 12/10/2025, the director acquired 1,836 shares of common stock as restricted stock at a price of $0. These restricted shares vest 100% on December 10, 2026.
Following this grant, the director beneficially owns 49,267 shares of common stock directly, 12,910 shares indirectly through a trust, and 36,000 shares indirectly through an IRA. The director also holds fully vested stock options covering 20,000 shares of common stock with an exercise price of $12.5 per share, expiring on 09/01/2026.
Esquire Financial Holdings, Inc. director reported acquiring 753 shares of restricted common stock on December 10, 2025 at a stated price of $0 per share. Following this grant, the director beneficially owns 72,401 shares of common stock directly.
The newly reported 753 restricted shares vest 100% on December 10, 2026. The total holding includes multiple prior restricted stock awards that vest in three equal annual installments beginning on December 19, 2023, December 9, 2025, December 19, 2026, December 3, 2027, and December 15, 2027. The director also holds fully vested stock options for 2,000 shares at $20.85 expiring December 16, 2030 and 1,750 shares at $31.04 expiring December 9, 2031.
Esquire Financial Holdings, Inc. disclosed that one of its directors received a grant of 753 shares of restricted common stock on December 10, 2025. The shares were awarded at $0 per share and are scheduled to vest 100% on December 10, 2026.
After this grant, the director beneficially owns 142,679 shares of common stock directly, which include multiple restricted stock awards that vest in three equal annual installments beginning on dates between December 19, 2023 and December 15, 2027. In addition, the director indirectly owns 2,500 shares through an insurance trust I and 2,500 shares through an insurance trust II.